Prevention of thrombogenesis in the extracorporeal circuit of hemodialysis with a low molecular heparin: standardization of the dosage with a better hemorrhagic risk/effectiveness ratio.
To test the efficacy and safety of a low molecular. Weight heparin (LMWH)--Fraxiparine, for hemodialysis (HD) anticoagulation, compared with conventional heparin (H) or serum lavage without other anticoagulation (L).Prospective controlled study.Twenty-nine consecutive patients referred for dialysis...
| Main Author: | |
|---|---|
| Other Authors: | , , , , , , , , |
| Format: | article |
| Language: | por |
| Published: |
1992
|
| Online Access: | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/3205 |
| Country: | Portugal |
| Oai: | oai:ojs.www.actamedicaportuguesa.com:article/3205 |